PereiraEBirnbaumL: A Potential Pitfall in the Use of the Monoraíl System for Carotid Stenting. A Technical Case Report. Interventional Neuroradiology12: 351–357,2006.
2.
SheikhKBullockC: Variation and changes in state-specific carotid endarterectomy and 30- day mortality rates. United States 1991–2000. J Vasc Surg38(4): 779–784, 2003.
3.
FergusonGGEliasziwM: The North American Symptomatic Carotid Endarterectomy Trial: Surgical results in 1415 patients. Stroke30 (9): 1751–1758, 1999.
4.
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST)Lancet351: 1379–1387, 1998.
5.
BarnettHJTaylorDW: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 12, 339(20): 1415–1425, 1998.
6.
YadavJSWholeyMH: Protected carotid-artery stenting versus endarterectomy in high-risk patients. For the Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. N Engl J Med351: 1493–1501, 2004.
7.
The SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial. Lancet368: 1239–1247, 2006.
8.
MasJChatellierG: Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. EVA-3S. N Engl J Med355, 1660–1671, 2006.
